Moreover, in breast cancer samples, TOM1L1 protein expression, assessed by immunohistochemistry (IHC) (Fig. 1b), was significantly associated with both ER (P=0.027) and ERBB2 (P=0.001) expression (Fig. 1c and Supplementary Table 3). Here, TOM1L1 is linked to breast carcinoma.